The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

@article{Moayyedi2014TheEO,
  title={The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis},
  author={Paul Moayyedi and Eamonn M M Quigley and Brian E. Lacy and Anthony J. Lembo and Yuri A Saito and Lawrence R. Schiller and Edy Soffer and Brennan M. R. Spiegel and Alexander Charles Ford},
  journal={The American Journal of Gastroenterology},
  year={2014},
  volume={109},
  pages={1367-1374}
}
OBJECTIVES:Fiber has been used for many years to treat irritable bowel syndrome (IBS). This approach had fallen out of favor until a recent resurgence, which was based on new randomized controlled trial (RCT) data that suggested it might be effective. We have previously conducted a systematic review of fiber in IBS, but new RCT data for fiber therapy necessitate a new analysis; thus, we have conducted a systematic review of this intervention.METHODS:MEDLINE, EMBASE, and the Cochrane Controlled… 

The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis

TLDR
Soluble fiber appears to improve symptoms of IBS, whereas there is no evidence for recommending insoluble fiber for IBS.

The role of fi ber supplementation in the treatment of irritable bowel syndrome : a systematic review and meta-analysis

TLDR
Soluble fiber appears to improve symptoms of IBS, whereas there is no evidence for recommending insoluble fiber for IBS.

Review: Fiber supplementation improves symptoms in the irritable bowel syndrome

TLDR
Overall, supplementation with fiber reduced persistence of IBS symptoms or abdominal pain with fiber supplementation vs placebo or no treatment, and the 2 largest RCTs of soluble fiber found similar benefit in IBS subtypes.

Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.

TLDR
In a network analysis of randomized controlled trials of secretagogues for IBS-C, all drugs were found to be superior to placebo.

Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence

TLDR
Although dietary interventions for IBS are frequently recommended, there is a paucity of data to support their use, so key questions about diets currently recommended for the treatment of the disorder are answered, using the best available data from the literature.

Editorial: fibre and FODMAPs in constipation and irritable bowel syndrome

  • K. Whelan
  • Medicine
    Alimentary pharmacology & therapeutics
  • 2015
TLDR
There was moderate evidence to support a recommendation for fibre supplementation in chronic constipation and IBS, whereas there was poor evidence toSupport a recommendation either for or against the use of the low FODMAP diet in IBS.

Irritable bowel syndrome and diet: where are we in 2018?

TLDR
It is clear that a low FODMAP diet has a beneficial effect in a majority of patients with IBS and probiotics also have great potential in the management of IBS; however, it is still unclear which strains and doses are the most beneficial.

Irritable bowel syndrome: a clinical review.

TLDR
The existing evidence on epidemiology, pathophysiology, and diagnosis of IBS is summarized to provide practical treatment recommendations for generalists and specialists according to the best available evidence.

The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence

TLDR
A narrative paper review of the existing and emerging evidence regarding dietary management of IBS patients is performed to enhance the understanding of how to move towards an individualized dietary approach for IBS Patients in the near future.
...

References

SHOWING 1-10 OF 36 REFERENCES

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

TLDR
Evaluating the efficacy of bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome found a beneficial effect for antidepressants over placebo for improvement of abdominal pain and subgroup analyses for different types of anti-inflammatory agents found statistically significant benefits.

Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome

TLDR
The addition of coarse wheat bran to the diet increased NSP ingestion and stool wet weight in this group of IBS patients, but no evidence was obtained that such treatment was of benefit to these patients, other than a placebo effect on symptoms.

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

TLDR
Fibre, antispasmodics, and peppermint oil were all more effective than placebo in the treatment of irritable bowel syndrome.

Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial.

TLDR
Linseeds may be useful in relief of IBS symptoms, but further research is needed to detect clear differences between the effects of whole and ground linseeds.

Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial

TLDR
Psyllium offers benefits in patients with irritable bowel syndrome in primary care and was more effective than placebo during the third month of treatment only; no differences were found with respect to quality of life.

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.

TLDR
The results of this trial suggest that bran and mebeverine are no ideal therapy for patients with IBS but they support the therapeutic use of bran in patients withIBS.

An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome

TLDR
This monograph was developed to educate physicians about its epidemiology, diagnostic approach, and treatments of Irritable Bowel Syndrome to critically evaluate the rapidly expanding research about IBS.

Ispaghula therapy in irritable bowel syndrome: Improvement in overall well‐being is related to reduction in bowel dissatisfaction

TLDR
There was a correlation between the improvement of well‐being and the number of days of satisfying bowel movements but not with the indexes of pain, stool frequency or changes in the transit time, suggesting the easing of bowel dissatisfaction appears to be a major reason for the therapeutic success of ispaghula in IBS.

Psyllium therapy in the irritable bowel syndrome. A double-blind trial.

TLDR
A major placebo effect occurs in patients with painful irritable bowel syndrome and is probably responsible for the efficacy of psyllium.